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ABSTRACT (400 words) 19 
 20 
Multiple controls established during the bovine spongiform encephalopathy (BSE) 21 
epidemic were not solely applied to BSE in cattle, but were implemented for scrapie in 22 
sheep and goats due to concerns over the occurrence of BSE in sheep. In the absence of 23 
BSE in sheep being observed, control measures for prion diseases are now being 24 
evaluated to ensure they remain proportionate to risk. This risk assessment, aims to 25 
estimate, by use of stochastic simulation, the impact of reducing controls for Specified 26 
Risk Materials (SRM) from sheep at abattoir. Three scenarios have been included: 1) 27 
current list of SRM; 2) brain and spinal cord of adult sheep; and 3) the brain of adult 28 
sheep. 29 
 30 
Results indicate the total amount of infectivity passing through British abattoirs is 31 
highest for atypical scrapie with nearly 3,500,000 Ovine Oral (OO) ID50 per year. The 32 
majority of this infectivity enters Category 1 waste for incineration, with only 13,000 33 
OO ID50 per year within edible products.  Under Scenario 2, an additional 4,000 OO 34 
ID50 per year would be classified as edible products from the lifting of restrictions on 35 
the distal ileum of adult sheep. However, if SRM removal was limited to brain, an 36 
additional 110,000 OO ID50 per year would be permitted into edible products with the 37 
lifting of restrictions on the spinal cord of adult sheep. 38 
 39 
For classical scrapie, there is a mean estimate of infectivity of 30,000 OO ID50 per year 40 
at abattoir. This is lower than for atypical scrapie due to the lower occurrence of this 41 
disease in Great Britain. However, more infectivity is destined to reach the food chain 42 
as the disease is peripherally distributed in the carcase. The highest contributor to the 43 
 3 
total amount of infectivity consumed per year is the intestines (duodenum and jejunum). 44 
If SRM removal is limited to the brain and spinal cord of sheep over 12 months of age, 45 
there is an approximate mean increase from 19,000 to 21,000 OO ID50 per year diverted 46 
to edible products. If the SRM list is restricted to brain only, this increases to over 47 
23,000 OO ID50 per year. 48 
 49 
For the potential of sheep-BSE, there is a very low estimate of 29 OO ID50 per year in 50 
total from carcases entering abattoir, due to the potential very rare occurrence of this 51 
disease. Given changes in SRM regulations there is a change of an additional 4 OO 52 
ID50 per year being diverted to edible products.  53 
 54 




In view of the steady decline in observed cases in European countries for Bovine 59 
Spongiform Encephalopathy (BSE) in cattle, European wide regulations have been 60 
amended to ensure that controls at the animal level and food chain are proportionate to 61 
the current level of risk. Such discussions are not limited to control measures focused 62 
on the prion protein in cattle, but also classical scrapie and atypical scrapie in sheep and 63 
goats. This is due to the escalation of controls on prions occurring in small ruminants 64 
in the wake of the BSE in cattle epidemic in the 1990s. Concern was high that detected 65 
scrapie in sheep may have been hiding the occurrence of BSE in small-ruminants which 66 
was justified subsequently after confirmation of naturally occurring BSE in goats (Eloit 67 
et al., 2005; Spiropoulos et al., 2011). In view of this concern, specified risk materials 68 
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(SRM) (Table 1) have been removed from small ruminant carcases at abattoir and 69 
categorised as the highest risk tissues defined as Category 1 materials. Such waste is 70 
incinerated to reduce any risk associated with use in the food chain or in the production 71 
of other protein materials such as Category 3 materials, which may be used in products 72 
such as pet food and soil improvers.  73 
 74 
For classical scrapie, both active and passive surveillance are vital in achieving the goal 75 
of eradicating the disease. Active surveillance began in January 2002 as a result of 76 
Regulation (EC) No. 999/2001 (EC, 2001) and the recommendation of the Spongiform 77 
Encephalopathy Advisory Committee (SEAC) to estimate the prevalence of sheep and 78 
goat scrapie in the British flocks. The programme includes surveys on the slaughtered 79 
population and the fallen stock on farm. In addition to this, passive surveillance is also 80 
conducted in parallel where suspect cases are reported and tested.  81 
 82 
The European Union (EU) requirement for testing sheep over 18 months of age for 83 
the United Kingdom (UK) is 20,000 in total with a baseline of 50% from sheep 84 
slaughtered for human consumption at abattoirs and 50% from fallen stock. However, 85 
the UK takes advantage of a derogation of the EU TSE Regulation to replace up to 86 
50% of their requirement for sheep tested for human consumption with the same 87 
number of sheep fallen stock. On this basis, the UK tests at least 5,000 sheep over 18 88 
months of age slaughtered for human consumption and the remaining 15,000 samples 89 
obtained from the fallen stock survey over 18 months to meet the overall requirement 90 
of 20,000. The EU requirement for testing fallen goats over 18 months of age is set at 91 
500 for the UK. Table 2 displays the results of UK surveillance from 2005 to 2016. 92 
 93 
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In the last 5 years new outbreaks of classical scrapie have not been confirmed in GB. 94 
The surveillance has been further enhanced by the introduction of the Compulsory 95 
Scrapie Flock Scheme (CSFS), which aims to closely monitor scrapie-affected holdings 96 
through surveillance of fallen stock and slaughtered animals. The holdings where 97 
scrapie has been confirmed are placed under movement restrictions, which lasts for two 98 
years following the detection of the last case of classical scrapie and follows the full 99 
implementation of the relevant controls, as appropriate, during which animals aged over 100 
18 months of age that die (fallen stock) or are killed for human consumption must be 101 
TSE tested. Should this monitoring option fail to be successful, the holding will be 102 
reassessed to where other options such as killing and destruction of all sheep or goats 103 
in the holding or compulsory culling of all sheep genetically susceptible to classical 104 
scrapie will be implemented as laid down in Annex VII of the EU TSE regulations. An 105 
additional control for classical scrapie was called “The National Scrapie Plan” or NSP, 106 
introduced in July 2001 and ending in 2012, which had the effect of reducing the most 107 
susceptible genotypes within the national sheep population. 108 
 109 
Atypical scrapie was first identified in Norway in 2003. Previous studies have not found 110 
any risk factors associated with an infectious origin suggesting that atypical scrapie in 111 
sheep is a spontaneous disease (Fediaevsky et al., 2009). However, oral transmission 112 
of atypical scrapie has been experimentally demonstrated (Simmons et al., 2011) 113 
suggesting this prion disease could be transmitted by feed and environmental pathways.  114 
 115 
BSE in small ruminants had been experimentally produced by the oral route (Foster et 116 
al., 1993) and it was known that BSE-infected bovine material in meat and bone meal 117 
feed was fed to small ruminants as protein supplements in the 1980s and 1990s. 118 
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Therefore it was not a significant surprise when two naturally occurring cases of 119 
classical BSE were found in goats, one in France, and one in Scotland. The Scottish 120 
case of BSE in a goat was originally tested and confirmed as a scrapie case in 1990. 121 
Following the confirmation of BSE in a goat in France in 2002 (Eloit et al., 2005), the 122 
UK carried out discriminatory immunohistochemistry on the scrapie positive goat 123 
samples. This case was found to be positive for BSE in 2005 (Jeffrey et al. 2006). Tissue 124 
samples from this case were further characterised by mouse bioassay and the outcomes 125 
reported in 2009 as BSE (Spiropoulos et al. 2011). 126 
With only two naturally occurring cases, it has been difficult to estimate an approximate 127 
prevalence of the occurrence of BSE in small ruminants. Kao and colleagues (2002) 128 
and Ferguson et al. (2002) used data from a small sample of brains (156 and 180, 129 
respectively) that were being studied by bioassay to estimate that approximately 2% of 130 
scrapie cases could be masking sheep-BSE at the 95% confidence limit. The 95% 131 
confidence limit is often quoted, rather than the mean, as selection bias and other 132 
complexities in the data make this the most appropriate estimate of the data available 133 
(Gravenor et al., 2003). Other risk assessments have utilized different maximum and 134 
minimum proportions of scrapie that are assumed to be sheep-BSE cases. Ferguson et 135 
al. (2002) utilized 0.5% to 2%, while Det Norske Veritas (DNV) (2001) used much 136 
larger intervals by considering arbitrary scenarios where the value ranged from a 137 
minimum of 0.01% to a maximum of 10%, with a “medium” value of 0.1%. In 2004, 138 
the Veterinary Laboratories Agency (VLA) reported to the Food Standards Agency 139 
(FSA) on the outcome of a 2-year project to screen brains of scrapie suspects using the 140 
method of Stack et al. (2002). Gubbins (2004) has used these data to estimate the 141 
maximum proportion of sheep TSE cases that could be BSE under different 142 
assumptions about the sample size. Based on the assumption that the cases tested 143 
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represent a random sample, the upper 95% confidence interval is that 0.14% of cases 144 
could be BSE positive. Finally in 2007, after the discovery of the two natural cases of 145 
small ruminant BSE, the European Food Safety Authority (EFSA) published an 146 
Opinion which calculated that, depending on the statistical model and the sub-set of 147 
input surveillance data, there was 95% confidence that in the UK there were less than 148 
2-4 sheep-BSE cases per 10,000 healthy-slaughter sheep (EFSA 2007). 149 
The BSE control model was a risk assessment developed in the UK to monitor the 150 
estimated amount of BSE infectivity from cattle entering the food chain each year based 151 
on current or theoretical surveillance and SRM control scenarios (Adkin et al., 2010). 152 
This work was previously developed under the TSE research portfolio in 2004, and has 153 
been subsequently updated and maintained under the surveillance contract, with annual 154 
results for GB provided to assist policy makers at Defra and FSA when considering the 155 
UK response to European proposals to change BSE legislation.  156 
 157 
Over the last few years a number of scrapie related projects have yielded data on the 158 
estimated occurrence and titres of scrapie infectivity in different tissue types for 159 
classical and atypical scrapie. Additional statistical work has used these data to 160 
parameterise certain variables of use in risk assessment. Given the interest at a European 161 
level for the deregulation of scrapie SRM controls in line with BSE control 162 
deregulation, a quantitative assessment on the infectivity arising from scrapie affected 163 
livestock at a national level would assist current policy considerations in this area. 164 
Therefore a risk assessment, termed the Scrapie Control Model, has been developed. 165 
Within the UK market, sheep meat dominants the proportion of meat consumed from 166 
small ruminants. In 2016, a provisional estimate of 289,590 tonnes of sheep meat and 167 
only 340 tonnes of goat meat were slaughtered for human consumption (Eurostat, 168 
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2017). Therefore, combined with a higher uncertainty regarding prion disease in goats, 169 
the risk assessment has been developed and parameterised only for sheep.  170 
 171 
This paper describes the quantification of the total amount of infectivity present in an 172 
infected sheep and lamb carcase for the prion diseases sheep-BSE, sheep classical 173 
scrapie and sheep atypical scrapie. In addition, the annual amounts of infectivity that 174 
subsequently enters the food chain, Category 1 materials and that are lost to the floor 175 
and diverted to drains are estimated for three SRM removal scenarios shown in Table 176 
3. 177 
 178 
METHODS  179 
Estimating the amount of infectivity was conducted by development of a probabilistic 180 
model with random variables and uncertain parameters described by appropriate 181 
probability distributions. The model was implemented in @Risk (© Palisade) Version 182 
6, an add-on package within Microsoft Excel (© Microsoft). The results presented 183 
follow the standard form of the arithmetic mean and the 5th and 95th percentile values. 184 
Accordingly the latter represent the range of values for which we are 90% certain that 185 
the true value lies between. The variables and parameters are described in each of the 186 
subsequent sections, with a summary of the values provided in Table 4.  187 
 188 
Model overview 189 
The risk assessment is divided into four components – Surveillance, Abattoir, 190 
Infectivity and the Annual extension. Parameters from the first three components are 191 
used to estimate the amount of infectivity per infected animal that has by-passed testing 192 
controls and entered the slaughterhouse for food production. These components are run 193 
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in a separate simulation (Model 1). The Annual extension uses the results from Model 194 
1 to estimate the annual amount of infectivity consumed nationally (Model 2). A 195 
summary diagram of the model framework outlining the links between the components 196 
in Model 1 and Model 2 is provided in Figure 1. 197 
 198 
Surveillance component 199 
The surveillance component estimates the number of infected adult sheep and lambs fit 200 
for human consumption, in the last 12 months of the incubation period, that enter 201 
abattoirs annually. The estimated number of infected animals at abattoir (N a,i), per 202 
animal group a  {S, l} and disease i  {bse, sc, at} is given by Equation (1): 203 
N a,i ~Poisson( P_infected i *N_animals a  )                            (1) 204 
where bse refers to sheep-BSE, sc to classical scrapie and at to atypical scrapie; S refers 205 
to sheep over 1 year of age and l denotes lambs (sheep less than 1 year of age). A 206 
Poisson distribution has been used to approximate the binomial distribution due to a 207 
large number of animals and small probability of infection. Sheep were divided into 208 
these two age groups because SRM controls are different for the two groups. For each 209 
animal group and disease, P_infected i denotes the probability that an individual animal 210 
is infected (i.e. prevalence of infection), and N_animals a the annual number of animals.  211 
 212 
The mean infection prevalence and 2.5th and 975.5th percentiles for classical scrapie at 213 
abattoir has been estimated previously (Ortiz-Pelaez and Arnold, 2008; Arnold and 214 
Ortiz-Pelaez, 2014). The prevalence has been updated by calculation of the trend 2005-215 
2017, derived from a confidence interval from the uncertainty in the trend parameter. 216 
This estimate includes sampling error but relies on the assumption that there has been 217 
a constant declining trend through the years 2005-2017 which cannot be verified in the 218 
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absence of any observed cases (Arnold, pers. comm. 2017). These estimated values are 219 
represented in the risk assessment by a Betapert distribution. This calculation of 220 
prevalence is not stratified by population genotype.  221 
 222 
There are little data for atypical scrapie cases. In the absence of further information, the 223 
Abattoir Survey was used to estimate the prevalence of atypical scrapie. A number of 224 
key assumptions were applied when using these data: (1) the incubation period of 225 
atypical scrapie was estimated from atypical passive surveillance and fallen stock 226 
positives, assuming fallen stock had reached clinical onset and died of scrapie (atypical 227 
scrapie is known to have a longer incubation period than classical scrapie); (2) the 228 
survivability of sheep infected with atypical scrapie is the same as for classical scrapie; 229 
and (3) the sensitivity of the post-mortem test for atypical scrapie is the same as for 230 
classical scrapie. The total number of lambs and sheep entering the abattoir, N_animals 231 
a,, is recorded by Defra statistics (Defra, 2015).   232 
 233 
As detailed in the introduction, prevalence values for sheep-BSE as a proportion of the 234 
estimated classical scrapie prevalence vary. From the most recent Opinion, the 235 
estimates from EFSA have been used in the risk assessment in the following equation:  236 
P_infected bse = P_infected sc * θsc  (2) 237 
where θsc is the proportion of scrapie that is assumed to be sheep-BSE. In a survey of 238 
2483 scrapie cases, the differential test for sheep-BSE was applied with 0 results.  239 
(Stack et al., 2002; SEAC, 2006). Results were 0 in sample size of 2483 cases, with the 240 
uncertainty associated with the probability of occurrence described in the assessment 241 
by a beta distribution with non-informative prior.   242 
 243 
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Infectivity component 244 
The infectivity component estimates the amount of infectivity by tissue type, in infected 245 
adult sheep and lambs in the last 12 months of the incubation period.  246 
Classical scrapie 247 
There are a number of tissues that have been identified as carrying significant levels of 248 
classical scrapie infectivity in sheep because of peripheral spread. The titre of 249 
infectivity Infectivity a,sc,t, (Ovine Oral (OO) ID50 per gram) was estimated by the 250 










,,,,     (3) 252 
where Max sc,t denotes the maximum titre of infectivity (log10 Mouse i.c. ID50 per gram) 253 
for tissue type t {1 to 14}. For tissues t = 1 to 9 estimates of infectivity were taken 254 
from Kimberlin and Wilesmith, (1994) with a mean value expressed as log10 Mouse i.c. 255 
ID50 per gram and standard error. The uncertainty about the maximum was described 256 
by a normal distribution (Table 4). Other tissues have been found to harbour infection 257 
or abnormal prion protein has been detected. Low levels of infectivity of the stomach, 258 
heart, and kidney (t = 10, 11 and 12) were described by point values (Kimberlin and 259 
Wilesmith 1994). In the absence of information regarding the infectivity titre of the 260 
duodenum and jejunum (t = 13), it was assumed that the level of infectivity in these 261 
tissues is the same as in the ileum (t = 6). This is a worst case assumption since the 262 
ileum is classified as SRM for sheep of all ages whereas the duodenum and jejunum are 263 
not. Evidence of classical scrapie infectivity has been detected in the blood of sheep at 264 
low titres (Kimberlin and Wilesmith 1994) and Andreoletti has investigated the 265 
transmission of scrapie through blood transmission with the use of transgenic mice 266 
tg338 (Andreoletti et al., 2012).  The minimum infectious dose for brain homogenate 267 
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was titrated by end point dilution in tg338 mice, with a titre of 106.6 ID50 IC/g 268 
(Andreoletti et al., 2011). The lowest dose resulting in transmission was observed in 269 
sheep (1 infection out of 2 challenged individuals) that were transfused with blood 270 
containing 103 ID50 IC in tg338 mice (Andreoletti et al., 2012). This equates to an 271 
approximate 4,000 fold reduction for blood as compared to brain homogenate. When 272 
applied in the risk assessment, this equates to blood containing the same infectivity as 273 
estimated for stomach and liver tissue. Low levels of infectivity have also been 274 
observed in the pituitary gland, cerebrospinal fluid and adrenal gland (Kimberlin and 275 
Wilesmith 1994). These tissues are respectively paired with the brain, spinal cord and 276 
kidney for ease of assessing the weight. Other tissues containing low amounts of 277 
infectivity are the PNS (Kimberlin and Wilesmith 1994; Hadlow et al.1982), tongue 278 
(Hadlow et al.,1982), bone marrow and supramammary lymph node (OIE 2009), and 279 
psoas muscles (Andreoletti et al., 2011). Given that the titre of infectivity in these 280 
tissues is considered very low, when compared to other infectious tissues which are 281 
being considered, these tissues were not quantitatively assessed. 282 
 283 
P_infectivity a,sc,t refers to the proportion of infectivity accumulated when an animal is 284 
slaughtered. The majority of clinical cases of classical scrapie appear in sheep between 285 
2 and 5 years of age (Kimberlin and Wilesmith 1994). During the progression of the 286 
disease, infectivity accumulates in different tissues at different rates. It is important to 287 
note that the vast majority of sheep are slaughtered before the age of 7 in the UK, are 288 
clinically in good health, and therefore, the disease may not be fully developed at 289 
slaughter. In this risk assessment, two age groups were considered, lambs under one 290 
year old and sheep over 1 year old. The percentage increase in infectivity at different 291 
ages was adjusted accordingly for lambs under one year of age (Kimberlin and 292 
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Wilesmith 1994), except for the lymph nodes and intestine (duodenum, jejunum and 293 
ileum) where the percentage of infectivity was estimated as 40% (Simmons, pers. 294 
comm. 2009). For sheep over the age of one year, the percentage of infectivity in all 295 
tissues was estimated to lie between 70 and 100% described by a uniform distribution 296 
(Simmons, pers. comm. 2009).  297 
 298 
A conversion factor, OOunit, was used to obtain approximations of the titres in units of 299 
Ovine Oral ID50 per gram. Titres of infection as calculated by intracerebral and 300 
intragastric routes of exposure (expressed as sample mean ± standard error of log10 ID50 301 
per 30 mg of mouse brain) are given in Kimberlin and Wilesmith, (1994). Using these 302 
data, the intracerebral route titre was described by a normal distribution with mean 7.03 303 
and variance 0.0169, and the intragastric route titre is described by a normal distribution 304 
with mean 2.03 and variance 0.0361. Since the values of these distributions are in units 305 
of log10, an estimate for OOunit is obtained by subtracting the intragastric route titre 306 
from the intracerebral route titre which results in a normal distribution with mean 5 and 307 
variance 0.053. 308 
Atypical scrapie 309 
The titre of infectivity (OO ID50 per gram) for tissues from animals infected with 310 
atypical scrapie, Infectivity a,at,t, was estimated by the following equation with values 311 










,,,,   (4) 313 
Max at,t denotes the maximum titre of infectivity (log10 Mouse i.c. ID50 per gram) by 314 
tissue type t. The number of potentially infectious tissues for atypical scrapie has been 315 
found to be much more restricted than for classical scrapie. Previous studies suggest 316 
that high levels of infection are limited to the central nervous system (CNS) and lymph 317 
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nodes as detected by the presence of PrPsc. However the use of more sensitive transgenic 318 
mice bioassay has been able to detect some cases of tissue infectivity present in the 319 
distal ileum in orally infected atypical cases (Simmons et al., 2011), brachial nerve, 320 
sciatic nerve and eye (external ocular muscle) from experimentally infected atypical 321 
cases via the intracerebral inoculation route (Andreoletti et al., 2011). In this risk 322 
assessment, it is assumed that the CNS (brain and spinal cord), lymph nodes, and distal 323 
ileum can become infectious for sheep infected with atypical scrapie.   324 
 325 
The titre of infectivity within atypical scrapie tissues has not been less widely reported 326 
in the literature and work in this area are ongoing. Andreoletti and colleagues reported 327 
on the results from 9 cases of atypical scrapie and 4 cases of classical scrapie for brain 328 
material shown in Table 5, together with estimates of infectivity cited in Kimberlin and 329 
Wilesmith (1994). The atypical infectivity titres shown in Table 4, are higher than for 330 
classical scrapie using the same mouse model (tg338) with a minimum percentage value 331 
of 100%, mean 105% and maximum of 132% of the value of infectivity estimated in 332 
the brain of a classical case. This may be due to the transgenic mouse model having a 333 
higher predilection for atypical proteins over classical, variation between animals in 334 
such a small sample size, or may represent a higher concentration of the prion protein 335 
in the brains of infected individuals. In this risk assessment, the worst case is assumed 336 
that brain material from atypical cases accumulate a higher percentage infectivity than 337 
classical scrapie described with uncertainty described using a pert distribution. 338 
 339 
To parameterise spinal cord, there are only one value found from experimentation of 340 
102.9 Titre ID50 IC/g tg338 from a case where the brain sample measured 10
5.8 Titre ID50 341 
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IC/g. Due to only one sample, a worst case assumption is used that the spinal cord has 342 
the same titre as classical scrapie. 343 
 344 
Limited infection has been demonstrated to be present in the peripheral tissues at low 345 
levels detectable by transgenic bioassay but not by PrPsc detection (Andreoletti et al., 346 
2011). The titre of infectivity has been estimated to be between 5 and 6 logs less than 347 
in CNS tissues (Simmons, per. comm., 2009; Andreoletti et al., 2011). This has been 348 
used in the risk assessment for lymph nodes and distal ileum, described by a uniform 349 
distribution. 350 
 351 
Based on only 8 clinical cases, the incubation period of atypical scrapie is at least 2 to 352 
3 times longer than for classical scrapie (Simmons, per. comm., 2009). Therefore, the 353 
distribution of infectivity with age has been adjusted: for lambs under one year old the 354 
percentages are thought to be negligible and represented in the assessment as 0.1% of 355 
the maximum clinical titre (Simmons, pers. comm. 2009). This is an important 356 
assumption which is further explored in the sensitivity analysis. For sheep over the age 357 
of one year, the percentage of infectivity in all of the tissues at the time of slaughter, 358 
P_infectivity S,at,t, is estimated to lie between 40 and 80%.  359 
BSE in sheep 360 
Experimental infection of classical BSE in sheep has been well documented 361 
(Andreoletti et al., 2006; Bellworthy et al., 2005; Jeffrey et al., 2001, 2015; Foster et 362 
al., 1993, 2001 a, b; Houston et al., 2015; Tan et al., 2012; McGovern et al., 2015, 363 
2016; van Keulen et al., 2008; Hunter et al., 2012). The sheep PRNP genotype has been 364 
found to influence both localisation of PrPd deposition and incubation rate. 365 
Experimental BSE infection has the shortest incubation period in sheep with the 366 
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ARQ/ARQ PRNP genotype (Foster et al., 2001b; Houston et al., 2003; van Keulen et 367 
al., 2008; Hunter et al., 2012; Tan et al., 2012) although the incubation period has also 368 
been found to be influenced by the genotype at codon 141 of the PRNP gene (Hunter 369 
et al., 2012; Tan et al., 2012), with LF heterozygotes having a longer mean incubation 370 
period than homozygotes of either type; the shortest incubation period was observed in 371 
LL141 sheep (Tan et al., 2012). Resistance in sheep to BSE challenge has also been 372 
found to be associated with the TARQ allele M112T PRNP variant (Saunders et al., 373 
2009; McGovern et al., 2015). Houston et al., (2015) found that out of eight clinically 374 
affected BSE-challenged ARQ/ARQ sheep examined, all had PrPd deposits in the 375 
spleen, mesenteric lymph node, and tonsil. Sheep of other PRNP genotypes showed 376 
more restricted distribution of PrPd in lymphoid tissues and there was no evidence of 377 
PrPd deposition in lymphoid tissues from BSE-infected sheep in the VRQ/ARR, 378 
ARQ/ARR or ARR/ARR groups apart from one sheep of ARQ/ARR genotype which 379 
was positive in spleen (Houston et al., 2015). In a similar study, neither PrPd nor 380 
infectivity was detected in any tissues of BSE-dosed ARQ/ARR or ARR/ARR sheep 381 
(McGovern et al., 2015).  382 
 383 
Breed of sheep may also influence their susceptibility to BSE challenge. Oral infection 384 
of Romney and Suffolk sheep with BSE-infected bovine brain material demonstrated 385 
that the brain, spinal cord, spleen, tonsil, ileum, and proximal colon could all be infected 386 
by BSE in infected sheep (Jeffrey et al., 2001). More recent studies on BSE infection 387 
of Romney and Suffolk sheep of the ARQ/ARQ or ARQ/ARR PRNP genotypes found 388 
that whilst all clinical BSE cases showed PrPd accumulation in the brain, 389 
lymphoreticular system (LRS) involvement within Romney recipients was significantly 390 
lower than for Suffolk sheep (McGovern et al., 2016). Differences between the two 391 
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breeds were noted in terms of involvement of LRS and enteric nervous system (ENS) 392 
tissues, with Romney sheep showing a more delayed and less consistent PrPd 393 
accumulation than Suffolk sheep in such tissues (McGovern et al., 2015). 394 
 395 
Time course studies of PrPd deposition following oral inoculation with BSE brain 396 
homogenate have found similar results of progression. Van Keulen et al., (2008) found 397 
initial accumulation of PrPd in the tonsil and the ileal Peyer’s patches then in all gut-398 
associated lymphoid tissues, lymph nodes and the spleen before spreading from the 399 
ENS to the medulla oblongata and the spinal cord. More recently, McGovern et al., 400 
(2015) found that in MARQ/MARQ sheep of Romney and Suffolk breeds, initial PrPd 401 
accumulation was identified in LRS tissues (retropharyngeal, prescapular, distal jejunal 402 
and prefemoral lymph nodes, palatine tonsil, spleen and jejunal and ileal Peyer's 403 
patches) followed by the CNS and ENS (jejunum and ileum) and finally in the 404 
autonomic nervous system and peripheral nervous system and other organs associated 405 
with infection for classical scrapie. Accumulations of PrPd have also been found in the 406 
liver of 100% of sheep challenged with BSE, compared to 89% of sheep naturally 407 
infected with scrapie, at both clinical and preclinical stages of the disease (Everest et 408 
al., 2011). 409 
 410 
The bovine atypical L-BSE strain of BSE can be intracerebrally transmitted to sheep of 411 
several genotypes, with the exception of ARR/ARR animals, but differs from challenge 412 
with classical BSE in that PrP accumulation is predominantly confined to the nervous 413 
system. In seventeen out of eighteen positive challenged animals, no immunoreactivity 414 
was detected in the liver, spleen, lymph nodes, distal ileum or rectoanal mucosa-415 
associated lymphoid tissue (Simmons et al., 2016). For classical BSE challenge, 416 
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Bellworthy et al. (2005) concluded that despite differences in the experimental 417 
protocols, it is safe to say that the spread of BSE infectivity through the sheep carcass 418 
reflects that reported by Hadlow et al. (1982) for naturally occurring scrapie. At the 419 
current time, such experimental data has not been linked to titre. Therefore, with no 420 
other information available, it is assumed that all tissues that are infected by scrapie are 421 
also infected by sheep-BSE with the same level of infectivity. 422 
 423 
Abattoir component 424 
The abattoir component estimates the total weight of each tissue type N_total a, t, from 425 
adult sheep and lambs, that are removed and (1) classified as food fit for human 426 
consumption including Category 3 materials, N_food a, t, (2) classified as Category 1 427 
high risk materials for disposal by incineration, N_cat1 a,t, and (3) falls to floor or 428 
washed down from equipment, N_floor a,t. These amounts were separately estimated 429 
for sheep and lambs under three scenarios shown in Table 3. Tissue weights and 430 
associated references are presented in Table 4.  431 
 432 
Sheep >12 months of age 433 
Blood lost at exsanguination is currently disposed of as Category 1 material through 434 
use of a blood tank. It is estimated that 40-60% (Kimberlin and Wilesmith 1994) of the 435 
total blood volume of a sheep (N_total S,14 2,720 g) is collected here. The amount of 436 
blood loss due to further processing, that was assumed to fall to the floor N_floor S,14, 437 
was estimated to be 10-20% of the original blood content (272-544 g). The remaining 438 
weight of blood is assumed to be associated with edible materials produced from the 439 
carcase N_food S,14.  440 
 441 
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Under current SRM regulations, the skull including brain and eyes (160 g) and tonsils 442 
(3.2g) are classified as SRM for sheep over one year old and are disposed of as Category 443 
1 material, N_cat1 S,1. There is a risk of contamination of meat from embolisms and 444 
operator transfer of brain tissue as a result of a captive bolt gun (CBG) being used to 445 
stun the animal. Coore et al., 2004 found that the frequency of brain tissue embolism 446 
was 23% in sheep stunned with a cartridge-activated CBG and 14% in those stunned 447 
with a pneumatically activated CBG. The number of sheep slaughtered in England and 448 
Wales using a stunning method is approximately 72.8% (FSA, 2017), and is split 449 
between CBG and electrical stunning with the later used more frequently (Anil, 2012).  450 
There are no data currently available on the proportion of sheep stunned by CBG, but 451 
using a pessimistic assumption that 40% of sheep are stunned with a CBG would result 452 
in an overall average proportion of 8.3% of carcases (if using cartridge-activated CBG) 453 
and 5.0% of carcases (if using pneumatically activated CBG) incurring an embolism 454 
event.  455 
 456 
In the risk assessment a most likely probability of 10% per carcase (minimum 1%, 457 
maximum 15%) is used with a most likely value of 1% brain weight transferred to 458 
food/category 3 materials per event (minimum 0.1%, 0.02%). This equates to an 459 
average of approximately 0.1 g contamination per carcase. This is lower than that 460 
estimated for cattle (Adkin et al., 2010) to take into account the lower likelihood of 461 
captive bolt used to stun sheep and less manual handing of the head during processing. 462 
Under Scenario 2 and 3, the tonsils are no longer removed as SRM. As a worst case it 463 




The spinal cord is removed for adult sheep as SRM under scenarios 1 and 2. However, 467 
inspections have shown that infrequently, small pieces of spinal cord may remain post 468 
abattoir controls in food or category 3 materials, N_food S,2. From an FSA survey in 469 
2007, from 260,833 inspections there were 13 failures (FSA, 2007). This is described 470 
in the risk assessment using a beta distribution. Given that there is a failure to correctly 471 
remove, between 0.05 and 1% of the spinal cord weight is assumed to remain, described 472 
using a uniform distribution. The amount of spinal cord material going to the floor, 473 
N_floor S, 2, was estimated to be the same proportion by weight as the amount of spinal 474 
cord which is lost to the floor for cattle, estimated by the following equation where t = 475 






















    (5) 477 
All remaining spinal cord is assumed to be removed as part of evisceration as disposed 478 
of as Category 1 materials, N_cat1 S,2. Under Scenario 3, it is assumed that spinal cord 479 
is diverted to edible materials.  480 
 481 
Upon evisceration it is assumed that a very small proportion of the spleen (300g) and 482 
ileum (200g) falls to the floor, between 0.01 and 0.1%, described using a uniform 483 
distribution (assessors assumption based on observation, 2009). This equates to a mean 484 
of less than a gram of tissue per carcase. The remainder is assumed to enter either 485 
Category 1 materials if classified as SRM or edible materials, in the absence of controls 486 
in Scenario 2. It was assumed that all other infectious sheep tissues remaining in the 487 
carcase enter edible materials. 488 
 489 
Lambs <12 months of age 490 
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The amount of infectious material going to the food chain, floor and Category 1 bin at 491 
abattoirs for lambs differs from sheep. This is due to different SRM controls being in 492 
place for sheep under 1 year old and lamb tissues weighing less than sheep (lamb tissue 493 
weights and references are given in Table 4).  494 
 495 
At exsanguination it was estimated that 40-60% of the total amount of blood in a lamb 496 
(N_total L,14 1,700 g) is disposed of as Category 1 material using a blood tank, N_cat1 497 
l,14 (Warriss 2000). The amount of blood falling to floor, N_floor l,14, was estimated to 498 
be between 170 and 340 g (10-20% of the original blood content). 499 
 500 
Unlike sheep aged over one year the skull, including brain, eyes and tonsils, are not 501 
classified as SRM and can be disposed of as Category 2 material. However, most 502 
abattoirs dispose of the head as Category 1 material in order to reduce collection costs. 503 
Infectious tissues associated with the head are the brain and eyes (100 g) and tonsils (2 504 
g). It was estimated that the amount of brain material which is lost to the floor due to 505 
handling of the head, N_floor l,1, is between 1 and 2 g (i.e. 1-2% of all brain material) 506 
and the amount transferred to meat is proportionally the same as that assessed for sheep. 507 
The remaining brain material is disposed of as Category 1 waste, N_cat1 l,1. Tonsils are 508 
assumed to remain on tongue meat removed for the food chain and Category 3 509 
materials. The spinal cord (40 g) is not classified as SRM for lambs and it is assumed 510 
that carcasses are not split to remove the vertebral column. Therefore all spinal cord is 511 
assumed to enter the food chain and category 3 materials, N_food l,2. The spleen (75 g) 512 
and the ileum (100 g) which are SRM for sheep of all ages in Scenario 1 were assumed 513 
to be removed at evisceration to Category 1 materials with the same proportions going 514 
to floor as for sheep. For Scenario 2, both tissues are assumed to enter the food chain 515 
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or Category 3 materials. All remaining lamb tissues in the carcase enter the food chain 516 
or Category 3 materials. 517 
 518 
Model 1 outputs 519 
As described in Fig. 1, the amount of contaminating tissues from the Abattoir 520 
component is multiplied separately, by tissue type, with the titre of infectivity in those 521 
tissues (ovine oral ID50/g) from the Infectivity component.  522 
 523 
Infectivity per carcase entering food chain and Category 3 materials, N_food a, t 524 
The amount of infectivity for each disease entering the food chain and Category 3 525 
materials (Oral ID50 per carcase), is estimated by multiplying the tissue weight by 526 
infectivity and summing for each animal group, as shown in equation (6): 527 
tia
t
taia yInfectivitfoodNfoodI ,,,, *__    (6) 528 
Infectivity per carcase entering Category 1 materials, N_cat1 a, t 529 
The amount of infectivity disposed of as Category 1 waste (Ovine Oral ID50 per 530 
carcase), is estimated by summing the amount of infectivity by tissue type and adding 531 
the total material retained by the trap, as shown in equation (7) 532 
𝐼_𝑐𝑎𝑡1𝑎,𝑖 = (∑ 𝑁_𝑐𝑎𝑡1𝑎,𝑡 ∗ 𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑎,𝑖,𝑡𝑡 ) + 𝐼_𝑡𝑟𝑎𝑝𝑎 (7) 533 
Where            𝐼_𝑡𝑟𝑎𝑝𝑎 = (∑ 𝑁_𝑓𝑙𝑜𝑜𝑟𝑎,𝑡𝑡 ∗ 𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑎,𝑖,𝑡) ∗ 𝑃_𝑡𝑟𝑎𝑝 534 
denotes the amount of infectivity (grams) that is retained in the trap and subsequently 535 
placed in the Category 1 bins for disposal and N_floor a,t is the amount in grams of 536 
infectious tissue type t that falls to the floor per carcase. 537 
 538 
Infectivity per carcase entering wastewater, N_drains a, t 539 
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Material falling to floor or washed from equipment will arrive at the mandatory 6mm 540 
trap and, potentially, enter the facility drains. There are two drain areas at abattoirs; one 541 
floor area includes the processing stages of stunning, head removal and bleeding and, 542 
if required, brain sampling for TSE testing, and flows into the blood tank which is 543 
disposed of as Category 1 as shown in Equation 7. Wash down from the floor areas for 544 
processing the remainder of the carcase will flow via the trap into wastewater. The 545 
amount of infectivity passing through the trap, and thus into the drains, I_draina,i, (OO 546 
ID50 per carcase) is estimated for sheep and lambs given by Equation (8) 547 
 trapPyInfectivitfloorNdrainI tia
t
taia _1**__ ,,,,   (8) 548 
where the percentage of infectivity retained by the trap is denoted P_trap.  549 
 550 
Proportion of infectivity retained by trap, P_trap 551 
It is a legal requirement for SRM handling facilities to have a 6 mm trap, with any 552 
sludge retained classified as Category 1 material (Saunier 2003). Research conducted 553 
by AFSSA attempted to measure the amount of CNS material that was retained at 554 
abattoir and the proportion that flowed through the trap (Saunier 2003). However, the 555 
experimental protocol used did not enable quantitative estimates. The proportion of 556 
material that is retained by the trap, P_trap, is based on those estimates available in the 557 
literature, between 0.8 and 0.9 (Saunier 2003; Kimberlin and Wilesmith 1994).  558 
 559 
Model 2: annual extension 560 
Model 2 estimates the annual amount of infectivity for pathogen i entering Category 1 561 
materials, the food chain and drainage by summing the amount of infectivity per 562 
infected sheep and lamb consumed as given by Equations (9) and illustrated in Figure 563 























A separate model is required to estimate the total annual infectivity due to the fact that 568 
each infected animal consumed would have different amounts of infectivity due to 569 
uncertainty and variability. The index variable j has been used to denote the random 570 
value for the number of infected animals per year generated by the distribution 571 
presented in Equation 1.  572 
 573 
RESULTS 574 
Uncertainty is considered in the model and results are represented using mean values 575 
followed by 5th and 95th percentiles in parentheses.  The model was run for 500,000 576 
iterations using Latin Hypercube sampling. It should be emphasised that not all 577 
uncertainty has been estimated in the calculations, as not all can be quantified. 578 
Therefore the 5th and 95th percentiles describe the amount of quantified uncertainty 579 
included in the model. 580 
 581 
Model 1 - Number of infected carcases at abattoir per year, N a,i 582 
Assuming a continuation of the decreasing trend in prevalence between 2005 and 2017, 583 
it is estimated that there were on average, 6 (1, 12) and 45 (20, 75) infected sheep and 584 
lambs with classical scrapie respectively entering GB abattoirs per year. For atypical 585 
scrapie this number increases to an annual total of 475 (220, 742) and 3563 (1658, 5549) 586 
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sheep and lambs infected with atypical scrapie. For BSE in sheep, it is estimated that a 587 
potential 0.002 (0, 0) and 0.02 (0, 0) sheep and lambs were infected per year. 588 
 589 
Model 1 - Amount of infectivity by exit destination per carcase 590 
Table 6 lists the risk assessment estimated values per carcase by disease for the amount 591 
of infectivity by exit destination. By comparing the results under each Scenario, it can 592 
be seen that for classical scrapie and sheep-BSE where disease is more peripherally 593 
distributed, the change in SRM regulations increases the amount of infectivity entering 594 
the food chain and category 3 materials by 220 OO ID50 per carcase for sheep and 27 595 
OO ID50 per carcase for lambs if SRM were restricted to the brain and spinal cord. 596 
Under Scenario 3, these values are estimated at 397 OO ID50 per carcase for sheep with 597 
the same value for lambs where only the brain is restricted. There is a far smaller change 598 
for atypical scrapie for Scenario 2 as the tissues that are no longer considered SRM are 599 
not thought to be significantly infectious for that disease, measured as a mean difference 600 
as 0.01 OO ID50 for sheep and 0.002 OO ID50 for lambs which is within the convergence 601 
limits of the model. Under Scenario 3, the infectious tissue spinal cord is no longer 602 
removed for adult sheep which results in an increase difference of 127 OO ID50 per 603 
carcase destined for the food chain rather than Category 1 waste with no difference 604 
found for lambs.  605 
 606 
Model 1 – Contribution by tissue type per carcase to infectivity entering food 607 
chain and category 3 materials  608 
Table 7 displays the contribution by tissue type to the total infectivity estimated to enter 609 
edible materials. It can be seen regardless of the SRM scenario that for classical scrapie 610 
the highest estimated contributor to infectivity is the intestines (assuming the worst case 611 
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that there is the same titre of infectivity as the ileum). However, if SRM controls are 612 
lifted, the spleen and ileum combined subsequently contribute around the 22% level in 613 
sheep and 11% in lambs of magnitude.  If spinal cord is removed from the list of 614 
specified risk materials, then that tissue increased to contribute approximately 15% to 615 
the total infectivity per carcase. For atypical scrapie, the lymph nodes dominate the 616 
contribution to total infectivity, unless ileum or spinal cord is deregulated from the list 617 
of SRM. 618 
 619 
Model 1 - Sensitivity analysis 
A multivariate stepwise regression analysis was used to calculate linear regression or 
sensitivity values for each value represented by a probability distribution. For all 
simulations of classical and atypical scrapie in sheep and lambs the results were all 
strongly affected by the uncertainty associated with the titre conversion factor, OOunit. 
Other parameters affecting the results were the maximum titre of classical scrapie 
infectivity in the brain, spinal cord, spleen and ileum, and the percentage of infectivity 
for sheep over one year old.  
 
Model 2 – Annual estimate of infectivity for GB 
The second model estimates the annual amount of infectivity for each of the prion 
diseases. From Table 8 it can be seen that the largest amount of infectivity generated 
per year is from atypical scrapie with a mean estimate of 3,500,000 OO ID50 per year. 
The majority of this infectivity enters Category 1 materials for incineration for scenario 
1 and 2. However, there is a significant difference between Scenario 2 and 3. Under 
baseline conditions, 0.4% of total infectivity enters edible products which increases to 
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0.5% under Scenario 2. By restricting SRM to the brain only increases this proportion 
to 3.5% of total infectivity entering food chain and Category 3 materials.  
 
For classical scrapie, there is less infectivity generated annually, with a mean estimate 
of 30,000 OO ID50 per year. This is lower than for atypical scrapie due to the lower 
estimated occurrence of this disease in the national flock. However, more infectivity is 
destined to reach the food chain and category 3 materials under all scenarios as the 
disease is peripherally distributed in many tissue types that are not classified as SRM. 
If SRM removal is limited to the brain and spinal cord of sheep > 12 months of age, 
there is an approximate mean increase of 2,000 OO ID50 per year diverted to the food 
chain rather than being destroyed as Category 1 materials under scenario 2 (brain and 
spinal cord removed) and a mean of over 4,000 OO ID50 per year if this is restricted to 
the brain only. 
 
For the potential of sheep-BSE still being present in the national flock, there is very low 
estimate of 29 OO ID50 per year generated from the national flock, due to the potential 
very rare occurrence of this disease. Given changes in SRM regulations there is a 
change of an additional 4 OO ID50 per year being diverted to the food chain and 
Category 3 materials. Due to convergence limits of the risk assessment, the small 
change between Scenario 2 and 3 cannot be distinguished in the results. 
 
An important assumption in the assessment, that lambs under 1 year would have 
negligible accumulation of atypical scrapie infectivity, was tested by increasing the 
baseline value from 0.1% to 1% of maximal infectivity in a clinical animal.  Results 
were an increase in the total infectivity per carcase from an average value of 2.27 to 
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22.7 OO ID50/lamb carcase. For absolute total accumulation per year, there was 
additional 12 fold infectivity entering the food chain and 9 fold entering Category 1 
materials. However, a change in this parameter value does not affect the relative results 
by SRM scenario as the change in the baseline value only affects lambs which are not 
subject to SRM control amendment.  
 
DISCUSSION 
Amongst abattoir controls that are subject to review are those intended to minimise the 
risk of scrapie and BSE from small ruminants exposure of consumers through food. 
This risk assessment has included three prion hazards for the national sheep flock of 
classical scrapie, atypical scrapie and sheep-BSE, when considering the impact of 
changes in the SRM controls at abattoir to infectivity being diverted to Category 1 waste 
for incineration, the food chain and Category 3 materials and abattoir wastewater.  
 
The risk assessment, assuming that there has been a continued decline in the prevalence 
of classical scrapie in the absence of cases, estimated a mean of approximately 30,000 
OO ID50 per year, with 65% of total infectivity present in meat products that are 
permitted in the food chain and Category 3 materials. If SRM removal is limited to the 
brain and spinal cord of sheep > over 12 months of age, there is an approximate mean 
increase of 2,000 OO ID50 per year diverted to the food chain, rising to over 4,000 OO 
ID50 per year if limited to brain only. This infectivity would be spread across a number 
of different carcases and tissues within that carcase, with the intestines contributing the 
highest levels. When viewing the absolute values generated by this risk assessment it is 
important to remember that the estimates of infectivity are dependent on the sensitivity 
of the detection method. Results in this risk assessment have been produced from, or 
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converted to the best approximation of, the infectivity as measured by bioassay in wild 
type mice due to this detection method having been used historically to test the highest 
number of samples, across the widest range of tissue types in sheep. Therefore, the key 
value of the risk assessment is in the relative comparisons for SRM control scenarios 
and identification of the data gaps.  
 
In terms of the relevant of the risk assessment to other countries, the variables has been 
parameterized for Britain. Given 1) the total number of sheep and lamb slaughtered 
annually, and 2) estimated prevalence for the three prion diseases, and 3) assuming 
similar abattoir practices, estimates for other countries could be quickly generated. 
Other countries in Europe are significantly affected by classical scrapie and therefore 
the impact of changing SRM controls for Britain may be different for other EU member 
states. 
 
From the sensitivity analysis the parameters with the greatest impact on the results are 
the uncertainty associated with disease characteristics of tissue infectivity and ID50 
conversion units, which have been found to significantly impact other TSE risk 
assessments (EFSA 2007, Adkin et al., 2010). Further data are currently being 
investigated at APHA which could be used to further reduce the uncertainty associated 
within risk assessment outputs. There are other key assumptions which influence the 
model results, whose impact has not been quantitatively evaluated but need highlighting 




The most important model assumption, when considering the aim of this work is to 
estimate the exposure of consumers via the food chain, is the degree of zoonotic 
potential of sheep prion diseases. BSE in cattle has been demonstrated as the cause of 
variant Creutzfeldt Jakob disease in humans, but the zoonotic potential of scrapie prions 
remains unknown. Various mice models genetically engineered to overexpress the 
human prion protein gene (tgHu) have been developed to investigate the capacity of 
prions to transmit to humans. For example, Cassard et al., 2014 demonstrated that 
scrapie prions can be transmitted to such humanized transgenic mice.  However, such 
models are difficult to validate. Epidemiological studies have so far found no links 
between scrapie and any human prion diseases. Sheep-BSE has been included in the 
risk assessment due to the links with Cattle-BSE. However, there are little quantitative 
titre data to parameterise the risk assessment. The worst case assumption is used that 
sheep-BSE is peripherally distributed using classical scrapie titres as a proxy.The 
outputs of the risk assessment are presented in units of ovine oral ID50 and with the 
uncertainty associated, no attempt has been made to estimate the species barrier 
required to cause infection and disease in people.  
 
Assumptions have been made to estimate the current prevalence of disease, with lambs 
affected to the same level as adult sheep. Great Britain is currently experiencing low 
levels of classical scrapie identified on farm and a trend analysis has been used to 
assume a continuing declining trend. One of the control strategies for scrapie was the 
National Scrapie Plan (NSP), led by APHA, which consisted of a breeding programme 
to increase the number of sheep that are naturally resistant to classical scrapie. This 
scheme was terminated in 2012. Given that the scheme may have contributed to the 
current low and declining occurrence of confirmed scrapie cases (Arnold and Ortiz-
 31 
Pelaez, 2014), and that the scheme has terminated, there may be a risk of a future 
increase in classical scrapie risk due to an increase in susceptible genotypes which 
would particularly impact the estimated prevalence in lambs.  
 
This risk assessment makes no distinction between prion protein genotypes, which are 
known to affect susceptibility to scrapie, incubation period, PrPsc tissue distribution and 
probably also infectivity, with different classical scrapie strains or sheep breeds 
possibly contributing to these differences. Nearly all studies in sheep with classical 
scrapie were carried out in sheep with fully susceptible genotypes, usually VRQ/VRQ, 
where PrPsc distribution is widespread and occurs early in the incubation period based 
on immunohistochemical examination whereas accumulation of PrPsc in lymphoid 
tissue may be limited in sheep with other genotypes (Ligios et al., 2005, González, et 
al., 2006). However, PrPsc detection does not always correlate well with infectivity 
(González et al., 2012). Sheep with an ARR/ARR genotype are believed to be generally 
resistant to classical scrapie although some natural cases have been reported (Groschup 
et al., 2007) and there is some debate whether sheep with this genotype simply act as 
asymptomatic carriers with an extremely long incubation period. Ultrasensitive in vitro 
methods, such as protein misfolding cyclic amplification which based on one 
experiment in ARQ/ARQ sheep may correlate well with infectivity (Chianini et al., 
2015), are increasing used to study disease susceptibility. One such study produced no 
significant amplification of PrPsc with brain from an ARR/ARR sheep (Bucalossi et al., 
2011), confirming the protective effect of this genotype. Due to these uncertainties, 
parameters in the assessment were taken from the worst-case scenario of sheep with a 
genotype fully susceptible to scrapie. 
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Atypical scrapie has been included as a hazard but little is known about sources of 
infection and epidemiology. Previous studies have not found any risk factors associated 
with an infectious origin suggesting that atypical scrapie in sheep is a spontaneous 
disease (Fediaevsky et al., 2009). However, experimental oral transmission of atypical 
scrapie has been experimentally demonstrated (Simmons et al., 2011) suggesting this 
prion disease could be transmitted by feed and environmental pathways to animals if 
present in sufficient doses. However, at the current time it is viewed that atypical scrapie 
is likely to be spontaneous in older animals originating in the brain and will continue to 
occur in GB at a constant, albeit very low level of approximately in 8 of 10,000 healthy 
slaughtered sheep (Ortiz-Peláez et al., 2016). 
 
It is estimated that there is a lower amount of atypical scrapie infectivity entering the 
food chain and Category 3 materials than classical scrapie, equalling approximately 
13,000 OO ID50 per year, despite the higher prevalence of atypical scrapie in the 
national flock. This is due to the limited distribution of infectivity in the CNS of 
atypical cases. Peripheral nerves and tissues have been found to be infected by 
transgenic bioassay, but at extremely low levels when compared to the CNS. There 
was an estimated small difference in the amount of atypical infectivity entering the 
food chain or Category 1 materials from a change in SRM controls limiting them to 
brain and spinal cord. This was estimated in the order of approximately 4,000 OO 
ID50 per year arising from very low levels of infectivity in distal ileum in adult sheep.  
However, under scenario 3, whereby only brain is classified as SRM, an additional 
mean estimate of 110,000 OO ID50 per year could be permitted into the food chain 
and Category 3 materials. 
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The titre of classical scrapie in the intestines (duodenum and jejunum) was not found 
in the literature. The titre is likely to be heterogeneously distributed depending on 
concentrations of gut-associated lymphoid tissue. In the absence of data, the titre was 
assumed to be the same as the ileum, with all three tissues ranked at the same level by 
the WHO as ‘lower infectivity tissues’ (WHO, 2010). This assumption and the heavy 
weight of these tissues, not classed as SRM, result in the tissues contributing the most 
to the edible fraction of an infected carcase. The estimate is likely to be an over-
estimate within the risk assessment, decreasing the absolute infectivity estimates, but 
would not impact the SRM scenario relative values. The WHO ranked list also lists a 
number of other ‘lower infectivity tissues’, which due to lack of data are not included 
in the risk assessment, but would form part of the edible fraction of the carcase. 
Inclusion of these tissues, if quantitative values could be gained, would slightly 
increase the absolute infectivity estimates, potentially balancing the overestimate for 
the intestines.  
 
Data on goats, which contribute a very small percentage to meat production in Britain, 
have not been included in this risk assessment. However, goats may represent a more 
scrapie-susceptible population than sheep because of the lack of national breeding 
programs to eradicate classical scrapie in this species. There is very limited 
knowledge about tissue infectivity and PrPsc distribution in classical scrapie-infected 
goats, which may not be similar to sheep. Indeed, the presence of PrPsc in pre-scapular 
lymph node tissue only in some classical scrapie-infected goats and the late and 
inconsistent detection of PrPsc in the enteric nervous system (Gonzalez et al., 2010) 
may suggest a different pathogenesis to sheep. There is even less information 
available about atypical scrapie in goats, which has not been found in the UK and is 
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less frequent than in sheep, with a prevalence of approximately 1 case per 10,000 tests 
(EFSA BIOHAZ Panel 2014). Whilst goats have not been covered in the assessment, 
if the number slaughtered for meat were included and using sheep estimated 
prevalence (atypical scrapie has never been found in UK goats and in 2017 there were 
no detected cases of goat classical scrapie), there would be a mean additional 0.04 
goats and 0.3 kids infected with classical scrapie, 3 goats and 24 kids infected with 
atypical scrapie, and 1.2 x 104 kids with goat-BSE. Given no further information on 
the difference in the pattern of infectivity in goats as compared to sheep, and the same 
small-ruminant SRM controls, inclusion of this highly uncertain data for goats in the 
risk assessment would slightly raise the absolute infectivity estimates, but would not 
impact the SRM scenario relative values.  
 
In conclusion, this assessment indicates that reducing the SRM controls for small-
ruminants at abattoir to the brain and spinal cord (Scenario 2) would cause little impact 
on the infectivity of prion diseased contaminating edible products. Limiting SRM to 
only the brain would cause more of a measurable impact, particularly for atypical 
scrapie increasing the proportion entering the food chain and Category 3 materials from 
0.5% to 3.5%.  
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Jeffrey, M., Martin, S., González, L., Ryder, S. J., Bellworthy, S. J. & Jackman, R. 
Differential diagnosis of infections with the bovine spongiform encephalopathy (BSE) 
and scrapie agents in sheep. J Comp Pathol 2001 125 271–284 
 
Jeffrey M., Martin S., González L., Foster J., Langeveld J. P., van Zijderveld F. G., 
Grassi J., Hunter N. Immunohistochemical features of PrP(d) accumulation in natural 
and experimental goat transmissible spongiform encephalopathies. J Comp Pathol 2006 
134 171–181  
 
Jeffrey, M., Witz, J. P., Martin, S., Hawkins, S. A. C., Bellworthy, S. J., Dexter, G. E., 
Thurston, L., González L. Dynamics of the natural transmission of bovine spongiform 
encephalopathy within an intensively managed sheep flock. Vet Res 2015 46 126 
 
Kao, R. R., Gravenor, M. B., Baylis, M., Bostock, C. J., Chihota, C. M., Evans, J. C., 
Goldmann, W., Smith, A. J. A. & McLean, A. R. The potential size and duration of an 
epidemic of bovine spongiform encephalopathy in British sheep. Science 2002 295 
332–335 
 
Kimberlin RH, Wilesmith JW. Bovine Spongiform Encephalopathy. Epidemiology, 
low dose exposure and risks. Ann N Y Acad Sci 1994 724 210-220. 
 
Ligios C, Cancedda MG, Madau L, Santucciu C, Maestrale C, Agrimi U, Ru G, Di 
Guardo G. PrP(Sc) deposition in nervous tissues without lymphoid tissue involvement 
is frequently found in ARQ/ARQ Sarda breed sheep preclinically affected with 
natural scrapie. Arch Virol. 2006 151 (10): 2007-2020. 
 
McGovern G, Martin S, Jeffrey M, Bellworthy SJ, Spiropoulos J3, Green R, Lockey R, 
Vickery CM, Thurston L, Dexter G, Hawkins SA, González L Influence of breed and 
genotype on the onset and distribution of infectivity and disease-associated prion 
protein in sheep following oral infection with the bovine spongiform encephalopathy 
agent J Comp Pathol. 2015 152 28-40  
 
McGovern G, Martin S, Jeffrey M, Dexter G, Hawkins SAC, Bellworthy SJ, , Thurston 
L, Algar L, González L (2016) Minimum Effective Dose of Cattle and Sheep BSE for 
Oral Sheep Infection. PLoS ONE 11(3) 
 
Ortiz-Pelaez A, Arnold M. Sheep scrapie surveillance 2008: Joint descriptive report for 
Great Britain. Centre for Epidemiology and Risk Analysis. Veterinary Laboratories 
Agency. Weybridge. December 2009. 
 
Ortiz-Peláez A, Arnold ME1, Vidal-Diez A Epidemiological investigations on the 
potential transmissibility of a rare disease: the case of atypical scrapie in Great Britain. 
Epidemiol Infect. 2016 144 2107-16  
 
Saunders GC, Lantier I, Cawthraw S, Berthon P, Moore SJ, Arnold ME, Windl O, 
Simmons MM, Andréoletti O, Bellworthy S, Lantier F Protective effect of the T112 
 40 
PrP variant in sheep challenged with bovine spongiform encephalopathy J Gen Virol. 
2009 Oct;90(Pt 10):2569-74.  
 
Saunier R. Risques sanitaires au regard de l’ESB liés aux rejets dans l’environnement 
des effluents et boues issus d’abattoirs et d’équarrissages. Agence Francaise de Securite 
Sanitaire des Aliments, France. September 2003. 
 
Simmons MM, Moore SJ, Konold T, Thurston L, Terry LA, Thorne L, Lockey R, 
Vickery C, Hawkins SA, Chaplin MJ, Spiropoulos J. Experimental oral transmission of 
atypical scrapie to sheep. Emerg Infect Dis. 2011 17 848-54  
 
Simmons MM, Chaplin MJ, Konold T, et al. L-BSE experimentally transmitted to sheep 
presents as a unique disease phenotype. Veterinary Research. 2016;47:112. 
doi:10.1186/s13567-016-0394-1. 
 
Spiropoulos J., Lockey R., Sallis R. E., Terry L. A., Thorne L., Holder T. M., Beck K. 
E., Simmons M. M. Isolation of prion with BSE properties from farmed goat. Emerg 
Infect Dis 2011 17 2253–2261   
 
Stack, M., Chaplin, M. & Clark, J. Differentiation of prion protein glycoforms from 
naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and 
SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot 
breed sheep experimentally inoculated with BSE using two monoclonal antibodies. 
Acta Neuropathol 2002 104 279–286. 
 
Tan BC, Blanco AR, Houston EF, Stewart P, Goldmann W, Gill AC, de Wolf C, 
Manson JC, McCutcheon S Significant differences in incubation times in sheep infected 
with bovine spongiform encephalopathy result from variation at codon 141 in the PRNP 
gene J Gen Virol. 2012 Dec;93(Pt 12):2749-56 
 
Terry LA, Howells L, Hawthorn J, Edwards JC, Moore SJ, Bellworthy SJ, Simmons H, 
Lizano S, Estey L, Leathers V, Everest SJ. Detection of PrPsc in blood from sheep 
infected with scrapie and bovine spongiform encephalopathy. J Virol 2009 83 12552-
12558 
 
Van Keulen LJM, Vromans MEW, Dolstra CH, Bossers A, van Zijderveld FG. 
Pathogenesis of bovine spongiform encephalopathy in sheep. Archives of Virology. 
2008;153(3):445-453. 
 
Warriss PD. Meat Science: An introductory text. Cabi Publishing. 2000. 
 
World Animal Health Organisation. OIE Terrestrial Manual 2009. Chapter 2.7.13 
Scrapie. 
http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.07.13_SCRAPIE.pd
f, Accessed January 2011.  
 
World Animal Health Organisation. WHO Tables on Tissue Infectivity Distribution in 
Transmissible Spongiform Encephalopathies. Updated 2010. 





Table 1: Designated specified risk material which are removed from sheep and goats 
by age in accordance with point 1 of Annex V of EC Regulation 999/2001 (as 
amended). Meat Industry Guide 2017 
 
Age Specified Risk material 
All Spleen and ileum 
Over 12 months (or have a 
permanent incisor erupted) 
Skull including the brains and eyes, tonsils, 
spinal cord 
 
Table 2: UK surveillance for classical and atypical scrapie from 2005 to 2016 
 








2005 11,864 17 16 9,683 29 6 
2006 48,971 8 36 21,225 38 13 
2007 26,469 6 19 15,214 19 15 
2008 10,761 2 5 11,793 6 6 
2009 11,255 3 16 10,819 2 9 
2010 8,423 1 13 10,460 0 6 
2011 7,423 2 11 12,725 3 12 
2012 7,009 0 11 13,452 2 18 
2013 7,254 0 3 12,842 3 13 
2014 7,396 0 4 12,866 0 7 
2015 5,488 0 9 14,767 2 6 





Table 3: Designated specified risk material in sheep and goats by age for Scenario 1 
(current regulations) and Scenario 2 and 3 (reduced regulations) 
 
Scenario 
Scenario 1 Scenario 2 Scenario 3 





Over 12 months: 
Skull including the 
brains and eyes, 
tonsils, spinal cord 
Over 12 months: Skull 
including the brains and 
eyes and spinal cord 
Over 12 months: 
Skull including 





Table 4: Parameter descriptions and values used within the risk assessment 
Parameter Symbol Value Unit Reference 
Surveillance component 
Prevalence of infection at 
abattoir in the last 12 months of 
the incubation period 
P_infected Sc Betapert(1.48x10-6, 3.16x10-6, 6x10-6) 
at the 2.5th, most likely and 97.5th  
% Arnold and Ortiz-Pelaez, 2014 updated by 
Arnold, pers. comm. 2017 
 P_infected At Betapert(1.1x10-4, 2.7x10-4, 4.54x10-4) 
at the 2.5th, most likely and 97.5th 
% Arnold and Ortiz-Pelaez, 2014 updated by 
Arnold, pers. comm. 2017 
Proportion of classical scrapie 
masking sheep-BSE 
θsc Beta(1, 2483+1) 
 
 Stack et al., 2002; SEAC, 2006 
Number of sheep slaughtered 
over 1 year old, per year  
N_animals S   1,712,000 head Defra, 2015 
Number of lambs slaughtered 
less than 1 year old, per year  
N_animals l  12,845,000 head Defra, 2015 
Infectivity component   
Conversion factor from Mouse 
i.c. ID50/g units to Ovine Oral 
ID50/g 
OOunit Normal (5,0.053) - Kimberlin and Wilesmith 1994 
Maximum titre of infectivity of 
Classical scrapie in tissue t 
Max sc,t t = 1: brain = Normal (5.6,0.04)† 
t = 2: spinal cord = Normal (5.4,0.09)† 
t = 3: lymph nodes = Normal (4.2,0.01)† 
t = 4: spleen = Normal (4.5,0.09)† 
t = 5: tonsils = Normal (4.2,0.16)† 
t = 6: ileum = Normal (4.7, 0.01)† 
t = 7: liver = Normal (2.0,0.01)† 
t = 8: pancreas = Normal (2.1,0.01)† 
t = 9: thymus = Normal (2.2,0.04)† 
t = 10: stomach = 2* 
t = 11: heart = 1* 
t = 12: kidney= 1* 
t = 13: duodenum & jejunum = Max sc,6   
t = 14: blood =  2  
log10 Mouse 
i.c. ID50/g 
† Kimberlin and Wilesmith 1994 
* Gale  2002 
  Andreoletti et al., 2011; Andreoletti et al., 2012 
Percentage of maximum 
infectivity in tissue t at time of 
death for Classical scrapie in 
sheep 
P_infectivity S,sc,t Uniform (70%,100%)  Data adapted Gale 2002 and Det Norske Veritas 
2002 
Percentage of maximum 
infectivity in tissue t at time of 
P_infectivity 
l,sc,t, 
for t = 1,2 
0.10%  Data adapted Gale 2002 and Det Norske Veritas 
2002 
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Parameter Symbol Value Unit Reference 




for t = 
4,5,7,8,9,10, 
11,12,14 




for t = 3,6,13 
40%  Data adapted Gale 2002 and Det Norske Veritas 
2002 
Maximum titre of Atypical 
scrapie infectivity in tissue t 
Max at,t t = 1: brain = Pert(100%, 105%, 132%) 
*Max sc,1 
t = 2: spinal cord = Max sc,2 
t = 3 and 4: lymph nodes and distal ileum 
= Max at,1 - Uniform (5, 6) 
log10 Mouse 
i.c. ID50/g 
Simmons, TSE National Reference Laboratory, 
APHA, per. comm., 2009; Andreoletti et al., 
2011. 
Percentage of maximum 
infectivity in tissue t at death 
for Atypical scrapie in sheep 
P_infectivity 
S,at,t, 
for t = 1,2,3,6 
Uniform (40%,80%)  Simmons, TSE National Reference Laboratory, 
APHA, per. comm., 2009 
Percentage of maximum 
infectivity in tissue t at death 
for Atypical scrapie in lambs 
P_infectivity 
l,at,t, 
for t = 1,2,3,6 
0.1%  Simmons, TSE National Reference Laboratory, 
APHA, per. comm., 2009 
Tissue weights 
Tissue weights for lambs N_carcasel ,t t = 1: brain = 100† 
t = 2: spinal cord = 40† 
t = 3: lymph nodes = 38  
t = 4: spleen = 75* 
t = 5: tonsils = 2  
t = 6: ileum = 100* 
t = 7: liver = 610† 
t = 8: pancreas = 100† 
t = 9: thymus = 50† 
t = 10: stomach = 1,000† 
t = 11: heart = 200† 
t = 12: kidney = 100† 
t = 13: duodenum & jejunum = 930  
t = 14: blood = 1,700† 
g †Assessors assumption based on Hart et al., 1997 
 Assessors assumption based on Fryer et al., 
2007 
* DARDNI 2009 
Tissue weights for sheep N_carcase S ,t t = 1: brain = Betapert(100,150,200) 
t = 2: spinal cord = Uniform(50*,64) 
g EFSA, 2014 
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Parameter Symbol Value Unit Reference 
t = 3: lymph nodes = 60.8 
t = 4: spleen = 300* 
t = 5: tonsils = 3.2 
t = 6: ileum = 200* 
t = 7: liver = 976 
t = 8: pancreas = 160 
t = 9: thymus = 80 
t = 10: stomach = 1,600 
t = 11: heart = 320 
t = 12: kidney = 160 
t = 13: duodenum & jejunum = 1,488 
t = 14: blood = 2,720 
Application of 1.6 scale factor Gale 2002  to 
weight of lamb tissue 
* DARDNI 2009 
Abattoir component 
Amount of blood lost to blood 
tank at exsanguination for 
scrapie  
 
N_Cat1 a,14 a = S: Uniform (0.4,0.6) * 2720 
a = l: Uniform (0.4,0.6) * 1700 
g Warriss, 2000 
Amount of blood to floor from 
further processing for scrapie 
 
N_floor a14 a = S: Uniform (0.1,0.2) * 2720 
a = l: Uniform (0.1,0.2) * 1700 
g Assessors assumption based on observation 
(2009); Hart et al., 1997 
Probability of brain material 
contaminating food fit for 
human consumption 
 
P_conta,1 Pert(0.01,0.1,0.15) % Coore et al., 2004; Anil, 2012, FSA, 2017, 
Assessors assumption (2017). 
Amount of brain material 
contaminating food fit for 
human consumption 
 
N_conta, 1 Pert(0.001,0.01,0.02) % brain wt Assessors assumption based on observation 
(2009) and comparison to cattle experimental 
data summarized in Adkin et al., 2010 
Amount of brain to floor for 
lambs 
 
N_floor l,1 Uniform (0.01,0.02) * 100 g Assessors assumption; Hart et al., 1997 
Amount of spinal cord to floor 
for scrapie 
 
N_floor S,2  (0.27 / Uniform (200,482)) * 64 g Assumed to be the same proportion of spinal cord 
to floor for cattle; Saunier  2003 
Probability of failure of spinal 
cord removal in sheep 
P_failureS,2 Beta(13+1, 260833-13+1) % UK Sheep (Ewes and Rams) slaughter data - 
DEFRA slaughter statistics 2007 
FSA, inspection data, 2007 
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Parameter Symbol Value Unit Reference 
Proportion of spinal cord left if 
failure to remove correctly 
P_cordS,2 Uniform(0.05,1) g Assessors assumption based on observation 
(2009) and comparison to cattle experimental 
data summarized in Adkin et al., 2010 
     




a=S, t=4: Uniform (0.0001,0.001) * 300 
a=l, t=4:  Uniform (0.0001,0.001) * 75 
a=S, t=6: Uniform (0.0001,0.001) * 200 
a=l, t=6:  Uniform (0.0001,0.001) * 100 
g Assessors assumption based on observation 
(2009); DARDNI 2009 
Proportion of infectivity retained by trap 
Proportion of material retained 
by 6 mm trap 
P_trap Uniform (0.8,0.9) % Adapted from Saunier  2003; Det Norske Veritas 





Table 5: Estimated infectious titre of brain materials for atypical and classical scrapie from the 1 
literature 2 
 3 
TSE isolate Number of samples 
and case origin 






1 sheep experimental 
intracerebral 
Cerebellum AFRQ/ARQ 108.7 
tg338 






















1 sheep natural Cortex ALRQ/ARR 106.7 
tg338 




















1 sheep natural Cerebellum AHQ/AHQ 106.7 
tg338 




1 sheep natural Cerebellum AHQ/AHQ 105.8 
tg338 




1 sheep natural Cerebellum ARR/ARR 105.8 
tg338 
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Table 6: Infectivity per infected carcase by exit destination by disease by animal group OO 6 






























( 377 , 
2547) 
+220 +397 











(0 , 0.2) 
0.1  
(0 , 0.2) 
0.1 






Food chain/Cat 3  224 
(73 , 490) 
251 
(82 , 549) 
251 
( 82 , 547) 
+27 +27 
Category 1 28  
(9 , 61) 
1 
(0.1 , 2) 
1 
(0.2 , 2) 
-27 -27 
Wastewater  0.01 
(0 , 0.02) 
0.01 
(0 , 0.02) 
0.01 








Food chain/Cat 3 2 
(0 , 9) 
2 
(0 , 9) 
127 
( 20 , 370) 
+0.01 +127 
Category 1 2041 
( 269 , 
6555) 
2041 
( 269 , 
6551) 
1914 




(0 , 0.05) 
0.02 
(0 , 0.05) 
0.02 
















Category 1 2 
(0.3 , 7) 
2 
(0.3 , 7) 
2 
(0.3 , 7) 
-0.002 -0.002 
Wastewater  0.005 
(0 , 0.02) 
0.005 
(0 , 0.02) 
0.005 
(0 , 0.02) 
0 0 
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Table 7: Percentage contribution by tissue type to infectivity in the food chain and category 3 materials by SRM scenario and disease for a single infected 12 
carcase (%) 13 
 14 
 Scenario 1: current SRM Scenario 2: brain & cord Scenario 3: brain 
 Classical scrapie Atypical scrapie Classical scrapie Atypical scrapie Classical scrapie Atypical scrapie 
Tissue type sheep lamb sheep lamb sheep lamb sheep lamb sheep lamb sheep lamb 
Brain & pituitary gland 0.1% 0.0% 9.3% 1.4% 0.1% 0.0% 9.3% 1.4% 0.1% 0.0% 1.4% 1.4% 
Spinal cord 0.0% 0.1% 0.0% 98.6% 0.0% 0.1% 0.0% 98.6% 14.8% 0.1% 98.5% 98.6% 
Lymph nodes 1.3% 1.3% 90.7% 0.0% 1.0% 1.2% 21.1% 0.0% 0.9% 1.2% 0.0% 0.0% 
Spleen 0.0% 0.0% 0.0% 0.0% 11.8% 1.4% 0.0% 0.0% 10.0% 1.4% 0.0% 0.0% 
Tonsils 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 
Ileum 0.0% 0.0% 0.0% 0.0% 10.3% 9.4% 69.5% 0.0% 8.7% 9.4% 0.0% 0.0% 
Liver 0.1% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 
Pancreas 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Thymus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Stomach 0.2% 0.1% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 
Heart 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Kidney & adrenal gland 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 
Intestines (duodenum & jejunum) 98.1% 98.4% 0.0% 0.0% 76.4% 87.7% 0.0% 0.0% 65.1% 87.7% 0.0% 0.0% 




Table 8: Infectivity annually by exit destination by disease OO ID50 per year for two 17 
scenarios: 1) current SRM removal, and 2) SRM restricted to brain & spinal cord, 3) SRM 18 
only brain 19 
 20 
 Scenario 1: current 
SRM 
Scenario 2: brain & 
cord 





Category 3  
19,320 
( 7,961 , 34,995) 
21,071 
(9,011 , 37,037) 
23,519 





(2,321 , 26,508) 
8515 
( 642 , 19,871) 
6,066 
(600 , 17,273) 
-1,751 -4,200 
 
Wastewater  1 
(0.4 , 3) 
1 
(0.4 , 3) 
1 




29,587 29,587 29,587   
Atypical scrapie 
Food chain/ 
Category 3  
13,079 
( 6,667 , 29,264) 
17,161 
( 5,262 , 22,023) 
122,242 





( 1,445,152 , 
6,366,002) 
3,500,191 






Wastewater  66 
( 43 , 126) 
67 
( 36 , 99) 
66 




3,517,419 3,517,419 3,517,419   
Sheep-BSE 
Food chain/ 
Category 3  
23 
( 0, 0 ) 
27 
( 0 , 0) 
28 





( 0 , 0) 
2 
( 0 , 0) 
2 
(0 , 0) 
-4 -4 
Wastewater  0.001 
( 0 , 0) 
0.001 
( 0 , 0) 
0.001 




29 29 29   
 21 
* difference due to convergence limits of risk assessment 22 
 23 
  24 
 52 
Table 9: Key assumptions and uncertainties not quantified in model results 25 
 26 




Impact on SRM 
scenario relative 
values 
There is a zoonotic 
potential of sheep 
prion diseases 
Level of species 
barrier which may 






Atypical scrapie is a 
transmissible disease 





















cohorts - lambs 
None 
Population is fully 







Intestines have the 
same infectivity as 
ileum 
Titre data Decrease None 
Not all ‘lower 
infectivity tissues’ 
included in risk 
assessment 
Titre data Increase None 














Number of infected sheep and lambs slaughtered per year
Number of sheep and 
lambs entering abattoir 
per year
Prevalence of infection 
of classical scrapie and 
atypical scrapie
Proportion of classical 
scrapie masking sheep-
BSE
Total amount of contamination per year in Great Britain (Ovine Oral ID50)
Infectivity
Titre of infectivity by 
tissue type, (Ovine Oral 
ID50/gram)
Abattoir
Weight of infectious 





Fig 1: Model framework of the Scrapie Control Model showing the links between 35 
Model 1; comprising of the Surveillance, Abattoir and Infectivity components and 36 
Model 2 the annual extension component 37 
 38 
 39 
 40 
 41 
